These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33413573)

  • 21. CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.
    Wang N; Liang S; Jin J; Fang L; Ma Q; Wang X; Song Y; Chen L
    Immunol Res; 2019 Dec; 67(6):486-496. PubMed ID: 31919790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CD226/TIGIT axis is involved in T cell hypo-responsiveness appearance in long-term kidney transplant recipients.
    Del Bello A; Gouin A; Chaubet C; Kamar N; Treiner E
    Sci Rep; 2022 Jul; 12(1):11821. PubMed ID: 35821240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
    Chauvin JM; Ka M; Pagliano O; Menna C; Ding Q; DeBlasio R; Sanders C; Hou J; Li XY; Ferrone S; Davar D; Kirkwood JM; Johnston RJ; Korman AJ; Smyth MJ; Zarour HM
    Clin Cancer Res; 2020 Oct; 26(20):5520-5533. PubMed ID: 32591463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4
    Kamrani A; Soltani-Zangbar MS; Shiri S; Yousefzadeh Y; Pourakbari R; Aghebati-Maleki L; Mehdizadeh A; Danaii S; Jadidi-Niaragh F; Yousefi B; Kafil HS; Hojjat-Farsangi M; Motavalli R; Zolfaghari M; Haji-Fatahaliha M; Mahmoodpoor A; Ahmadian Heris J; Emdadi A; Yousefi M
    Immunol Invest; 2022 May; 51(4):1023-1038. PubMed ID: 33855917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered CD226/TIGIT expressions were associated with NK phenotypes in primary antiphospholipid syndrome and affected by IL-4/JAK pathway.
    Long Y; Lu KJ; Xia CS; Feng JH; Li WY; Ma YT; Sun YY; Fan CH; Li C
    Clin Exp Immunol; 2024 Apr; 216(2):132-145. PubMed ID: 38386917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.
    Arruga F; Rubin M; Papazoglou D; Iannello A; Ioannou N; Moia R; Rossi D; Gaidano G; Coscia M; Laurenti L; D'Arena G; Allan JN; Furman RR; Vaisitti T; Ramsay AG; Deaglio S
    Haematologica; 2023 Aug; 108(8):2101-2115. PubMed ID: 36655432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
    Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
    Front Immunol; 2018; 9():2341. PubMed ID: 30364127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
    Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
    PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.
    Shibuya A; Shibuya K
    Int Immunol; 2021 Nov; 33(12):687-692. PubMed ID: 34694361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helios but not CD226, TIGIT and Foxp3 is a Potential Marker for CD4
    Yang M; Liu Y; Mo B; Xue Y; Ye C; Jiang Y; Bi X; Liu M; Wu Y; Wang J; Olsen N; Pan Y; Zheng SG
    Cell Physiol Biochem; 2019; 52(5):1178-1192. PubMed ID: 30990587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase.
    Inozume T; Yaguchi T; Furuta J; Harada K; Kawakami Y; Shimada S
    J Invest Dermatol; 2016 Jan; 136(1):255-63. PubMed ID: 26763445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TIGIT/CD226 Axis Regulates Anti-Tumor Immunity.
    Yeo J; Ko M; Lee DH; Park Y; Jin HS
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33670993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of aspirin in the prevention of colorectal cancer through TIGIT-CD155 pathway.
    Ma B; Duan X; Zhou Q; Liu J; Yang X; Zhang D; Yang S; Du Y; Li H; Su C
    J Cell Mol Med; 2019 Jul; 23(7):4514-4522. PubMed ID: 31090213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation.
    Worboys JD; Vowell KN; Hare RK; Ambrose AR; Bertuzzi M; Conner MA; Patel FP; Zammit WH; Gali-Moya J; Hazime KS; Jones KL; Rey C; Jonjic S; Rovis TL; Tannahill GM; Cruz De Matos GDS; Waight JD; Davis DM
    Nat Commun; 2023 Aug; 14(1):5016. PubMed ID: 37596248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain on CD4
    Kurita M; Yoshihara Y; Ishiuji Y; Chihara M; Ishiji T; Asahina A; Yanaba K
    J Dermatol; 2019 Jan; 46(1):37-42. PubMed ID: 30402886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIGIT expression levels on CD4+ T cells are correlated with disease severity in patients with psoriasis.
    Wang FF; Wang Y; Wang L; Wang TS; Bai YP
    Clin Exp Dermatol; 2018 Aug; 43(6):675-682. PubMed ID: 29512851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis.
    Yu Y; Chen Z; Wang Y; Li Y; Lu J; Cui L; Yu Z; Ding Y; Guo C; Zhang X; Shi Y
    Int Immunopharmacol; 2021 Jul; 96():107722. PubMed ID: 33965878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin Inhibits Colorectal Cancer via the TIGIT-BCL2-BAX pathway in T Cells.
    Liu J; Zhou Q; Meng K; Yang X; Ma B; Su C; Duan X
    Int J Med Sci; 2024; 21(10):1990-1999. PubMed ID: 39113892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competitive binding of CD226/TIGIT with poliovirus receptor regulates macrophage polarization and is involved in vascularized skin graft rejection.
    Zhang D; Liu Y; Ma J; Xu Z; Duan C; Wang Y; Li X; Han J; Zhuang R
    Am J Transplant; 2023 Jul; 23(7):920-934. PubMed ID: 37054890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.
    Ackermann C; Smits M; Woost R; Eberhard JM; Peine S; Kummer S; Marget M; Kuntzen T; Kwok WW; Lohse AW; Jacobs T; Boettler T; Schulze Zur Wiesch J
    Sci Rep; 2019 Jul; 9(1):10624. PubMed ID: 31337800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.